MENU
+Compare
PDEX
Stock ticker: NASDAQ
AS OF
Nov 13 closing price
Price
$31.84
Change
-$0.64 (-1.97%)
Capitalization
103.44M

PDEX Pro-Dex Forecast, Technical & Fundamental Analysis

Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries... Show more

PDEX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for PDEX with price predictions
Nov 13, 2025

Aroon Indicator for PDEX shows an upward move is likely

PDEX's Aroon Indicator triggered a bullish signal on November 13, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 164 similar instances where the Aroon Indicator showed a similar pattern. In of the 164 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 27, 2025. You may want to consider a long position or call options on PDEX as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PDEX just turned positive on October 24, 2025. Looking at past instances where PDEX's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for PDEX crossed bullishly above the 50-day moving average on November 11, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PDEX advanced for three days, in of 262 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for PDEX moved out of overbought territory on November 04, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 49 cases where PDEX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

PDEX moved below its 50-day moving average on November 13, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PDEX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PDEX broke above its upper Bollinger Band on October 31, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PDEX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.492) is normal, around the industry mean (10.086). P/E Ratio (9.548) is within average values for comparable stocks, (153.436). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.600). PDEX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (1.523) is also within normal values, averaging (110.982).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PDEX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
PDEX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

PDEX is expected to report earnings to fall 57.86% to 58 cents per share on January 29

Pro-Dex PDEX Stock Earnings Reports
Q4'25
Est.
$0.59
Q3'25
Beat
by $0.90
Q2'25
Missed
by $0.12
Q1'25
Beat
by $0.55
Q4'24
Beat
by $0.28
The last earnings report on October 30 showed earnings per share of $1.40, beating the estimate of 50 cents. With 19.77K shares outstanding, the current market capitalization sits at 103.44M.
A.I. Advisor
published General Information

General Information

a producer of powered solutions

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
2361 McGaw Avenue
Phone
+1 949 769-3200
Employees
146
Web
https://www.pro-dex.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRRCF0.01N/A
+16.28%
VR Resources Ltd.
BEVFF2.640.12
+4.76%
Diversified Royalty Corp.
CYJBF64.00N/A
N/A
HIAB OYJ
LNVGY27.62-0.60
-2.13%
Lenovo Group Ltd.
AOTVF0.03N/A
-7.41%
Ascot Resources Ltd.

PDEX and Stocks

Correlation & Price change

A.I.dvisor tells us that PDEX and LMAT have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PDEX and LMAT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDEX
1D Price
Change %
PDEX100%
-3.36%
LMAT - PDEX
28%
Poorly correlated
-0.44%
LDXHF - PDEX
25%
Poorly correlated
N/A
TCMD - PDEX
24%
Poorly correlated
-2.03%
PRE - PDEX
23%
Poorly correlated
+7.27%
BDX - PDEX
23%
Poorly correlated
+1.64%
More

Groups containing PDEX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDEX
1D Price
Change %
PDEX100%
-3.36%
Pharmaceuticals: Other
industry (103 stocks)
9%
Poorly correlated
-1.40%
Pharmaceuticals
industry (378 stocks)
5%
Poorly correlated
-0.99%